SCHEMBL4324629

SCHEMBL4324629

Fc1ccc(ON2CCCC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.44
LTA4H P09960 1/20 0.44
MEN1 O00255 1/20 0.44
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44
HRH3 Q9Y5N1 2/20 0.43
GAA P10253 1/20 0.43
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
ATM Q13315 1/20 0.38
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5169785 0.98 HRH3 (0.46) KMT2ALTA4HMEN1LMNAHTT
SCHEMBL188044 0.85 ALDH1A1 (0.41) KMT2AMEN1HTTHRH3ATM
SCHEMBL7434267 0.81 HTR1A (0.50) HRH3
Trifluoroacetic Acid SCHEMBL23853450 0.80 GAA (0.48) KMT2ALMNAHRH3GAARAB9A
SCHEMBL30480164 0.77 LTA4H (0.44) KMT2ALTA4HMEN1HTTGAA
SCHEMBL30065109 0.77 LTA4H (0.49) KMT2ALTA4HMEN1HRH3KDM4E
SCHEMBL443667 0.76 HRH3 (0.45) KMT2AMEN1HRH3GAANPC1
SCHEMBL22031681 0.76 HRH3 (0.39) LTA4HHRH3ALDH1A1
SCHEMBL4750348 0.76 HRH3 (0.46) KMT2ALTA4HMEN1HTTHRH3
SCHEMBL3164216 0.76 ALDH1A1 (0.52) HTTHRH3GAAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009143153-A1 SUBSTITUTED PYRROLIDINE AMIDES AS MODULATORS OF THE HISTAMINE H3 RECEPTOR JANSSEN PHARMACEUTICA NV (BE) 2009-11-26 WO claimed
EP-3883925-A1 CYCLIC UREAS Sironax Ltd (KY) 2021-09-29 EP disclosed
US-8236792-B2 Substituted pyrrolidine amides as modulators of the histamine H3 receptor JANSSEN PHARMACEUTICA NV (BE) 2012-08-07 US disclosed
US-20090291903-A1 SUBSTITUTED PYRROLIDINE AMIDES AS MODULATORS OF THE HISTAMINE H3 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2009-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291903-A1 SUBSTITUTED PYRROLIDINE AMIDES AS MODULATORS OF THE HISTAMINE H3 RECEPTOR HRH3, HRH4, HRH2 KMT2A 183/4885LTA4H 623/4885MEN1 3662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.